<?xml version='1.0' encoding='utf-8'?>
<document id="26547877"><sentence text="New insights into the risk of phthalates: Inhibition of UDP-glucuronosyltransferases." /><sentence text="Wide utilization of phthalates-containing products results in the significant exposure of humans to these compounds" /><sentence text=" Many adverse effects of phthalates have been documented in rodent models, but their effects in humans exposed to these chemicals remain unclear until more mechanistic studies on phthalate toxicities can be carried out" /><sentence text=" To provide new insights to predict the potential adverse effects of phthalates in humans, the recent study investigated the inhibition of representative phthalates di-n-octyl ortho-phthalate (DNOP) and diphenyl phthalate (DPhP) towards the important xenobiotic and endobiotic-metabolizing UDP-glucuronosyltransferases (UGTs)"><entity charOffset="193-197" id="DDI-PubMed.26547877.s4.e0" text="DNOP" /><entity charOffset="203-221" id="DDI-PubMed.26547877.s4.e1" text="diphenyl phthalate" /><entity charOffset="223-227" id="DDI-PubMed.26547877.s4.e2" text="DPhP" /><pair ddi="false" e1="DDI-PubMed.26547877.s4.e0" e2="DDI-PubMed.26547877.s4.e0" /><pair ddi="false" e1="DDI-PubMed.26547877.s4.e0" e2="DDI-PubMed.26547877.s4.e1" /><pair ddi="false" e1="DDI-PubMed.26547877.s4.e0" e2="DDI-PubMed.26547877.s4.e2" /><pair ddi="false" e1="DDI-PubMed.26547877.s4.e1" e2="DDI-PubMed.26547877.s4.e1" /><pair ddi="false" e1="DDI-PubMed.26547877.s4.e1" e2="DDI-PubMed.26547877.s4.e2" /></sentence><sentence text=" An in vitro UGTs incubation system was employed to study the inhibition of DNOP and DPhP towards UGT isoforms"><entity charOffset="76-79" id="DDI-PubMed.26547877.s5.e0" text="DNOP" /><entity charOffset="85-88" id="DDI-PubMed.26547877.s5.e1" text="DPhP" /><pair ddi="false" e1="DDI-PubMed.26547877.s5.e0" e2="DDI-PubMed.26547877.s5.e0" /><pair ddi="false" e1="DDI-PubMed.26547877.s5.e0" e2="DDI-PubMed.26547877.s5.e1" /></sentence><sentence text=" DPhP and DNOP weakly inhibited the activities of UGT1A1, UGT1A7, and UGT1A8"><entity charOffset="10-13" id="DDI-PubMed.26547877.s6.e0" text="DNOP" /><entity charOffset="1-4" id="DDI-PubMed.26547877.s6.e1" text="DPhP" /><pair ddi="false" e1="DDI-PubMed.26547877.s6.e1" e2="DDI-PubMed.26547877.s6.e1" /><pair ddi="false" e1="DDI-PubMed.26547877.s6.e1" e2="DDI-PubMed.26547877.s6.e0" /></sentence><sentence text=" 100 µM of DNOP inhibited the activities of UGT1A3, UGT1A9, and UGT2B7 by 41"><entity charOffset="11-14" id="DDI-PubMed.26547877.s7.e0" text="DNOP" /></sentence><sentence text="8% (p &lt; 0" /><sentence text="01), 45" /><sentence text="6% (p &lt; 0" /><sentence text="01), and 48" /><sentence text="8% (p &lt; 0" /><sentence text="01), respectively" /><sentence text=" 100 µM of DPhP inhibited the activity of UGT1A3, UGT1A6, and UGT1A9 by 81"><entity charOffset="11-14" id="DDI-PubMed.26547877.s14.e0" text="DPhP" /></sentence><sentence text="8 (p &lt; 0" /><sentence text="001), 49" /><sentence text="1% (p &lt; 0" /><sentence text="05), and 76" /><sentence text="4% (p &lt; 0" /><sentence text="001), respectively" /><sentence text=" In silico analysis was used to explain the stronger inhibition of DPhP than DNOP towards UGT1A3 activity"><entity charOffset="77-80" id="DDI-PubMed.26547877.s21.e0" text="DNOP" /><entity charOffset="67-70" id="DDI-PubMed.26547877.s21.e1" text="DPhP" /><pair ddi="false" e1="DDI-PubMed.26547877.s21.e1" e2="DDI-PubMed.26547877.s21.e1" /><pair ddi="false" e1="DDI-PubMed.26547877.s21.e1" e2="DDI-PubMed.26547877.s21.e0" /></sentence><sentence text=" Kinetics studies were carried our to determine mechanism of inhibition of UGT1A3 by DPhP"><entity charOffset="85-88" id="DDI-PubMed.26547877.s22.e0" text="DPhP" /></sentence><sentence text=" Both Dixon and Lineweaver-Burk plots showed the competitive inhibition of DPhP towards UGT1A3"><entity charOffset="75-78" id="DDI-PubMed.26547877.s23.e0" text="DPhP" /></sentence><sentence text=" The inhibition kinetic parameter (Ki) was calculated to be 0" /><sentence text="89 µM" /><sentence text=" Based on the [I]/Ki standard ([I]/Ki &lt; 0" /><sentence text="1, low possibility; 1&gt;[I]/Ki &gt; 0" /><sentence text="1, medium possibility; [I]/Ki &gt; 1, high possibility), these studies predicted in vivo drug-drug interaction might occur when the plasma concentration of DPhP was above 0"><entity charOffset="153-156" id="DDI-PubMed.26547877.s28.e0" text="DPhP" /></sentence><sentence text="089 µM" /><sentence text=" Taken together, this study reveales the potential for adverse effects of phthalates DNOP and DPhP as a result of UGT inhibition"><entity charOffset="85-88" id="DDI-PubMed.26547877.s30.e0" text="DNOP" /><entity charOffset="94-97" id="DDI-PubMed.26547877.s30.e1" text="DPhP" /><pair ddi="false" e1="DDI-PubMed.26547877.s30.e0" e2="DDI-PubMed.26547877.s30.e0" /><pair ddi="false" e1="DDI-PubMed.26547877.s30.e0" e2="DDI-PubMed.26547877.s30.e1" /></sentence><sentence text="" /></document>